PTGS2 and breast carcinoma: Using gene expression and miRNA microarray assays, we have identified that the overexpression of COX-2 in a poorly metastatic MCF7 cells (an ER/PR-positive and HER2-negative breast cancer cell line) upregulates two miRNAs, miR526b and miR655, which have been classified as oncogenic miRNAs in human breast cancer [13,14].